CD44 and neoplasm: While common biomarkers such as CD133, CD44, EpCAM, and ALDH are identified in CSCs across various tumor types, the heterogeneity of cancers often necessitates the utilization of multiple markers or a combination of intracellular and extracellular markers for the isolation and characterization of CSCs (31).